VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ABT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ABTAbbott Laboratories
$92.71$161.5B
Overview & Verdict
OverviewShould I Buy?
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksABTQuarterly Financials

Abbott Laboratories (ABT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Abbott Laboratories (ABT) quarterly income statement — complete revenue, gross profit & net income history

ABT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue11.16B11.46B11.37B11.14B10.36B10.97B10.63B10.38B9.96B10.24B10.14B9.98B9.75B10.09B10.41B11.26B11.89B11.47B10.93B10.22B
Revenue Growth %7.78%4.42%6.9%7.37%3.95%7.16%4.85%4%2.23%1.49%-2.56%-11.36%-18.06%-12.01%-4.74%10.11%13.76%7.17%23.44%39.51%
Cost of Goods Sold4.88B4.92B5.03B4.85B4.91B5.38B5.21B5.07B4.94B4.98B5.11B5.03B4.94B5.12B5.2B5.48B5.53B5.26B4.87B4.85B
COGS % of Revenue43.72%42.95%44.25%43.56%47.44%48.99%48.98%48.88%49.6%48.66%50.37%50.44%50.7%50.74%49.96%48.71%46.46%45.86%44.55%47.42%
Gross Profit6.28B6.54B6.34B6.29B5.44B5.6B5.43B5.3B5.02B5.26B5.03B4.95B4.8B4.97B5.21B5.77B6.37B6.21B6.06B5.38B
Gross Margin %56.28%57.05%55.75%56.44%52.56%51.01%51.02%51.12%50.4%51.34%49.63%49.56%49.3%49.26%50.04%51.29%53.54%54.14%55.45%52.58%
Gross Profit Growth %15.41%16.77%16.81%18.53%8.4%6.47%7.79%7.28%4.52%5.77%-3.36%-14.36%-24.56%-19.94%-14.04%7.42%14.34%9.18%39.89%54.41%
Operating Expenses4.44B4.29B4.31B4.24B3.76B3.61B3.61B3.62B3.64B3.39B3.36B3.43B3.4B3.53B3.51B3.44B3.48B3.76B3.44B3.38B
OpEx % of Revenue39.78%37.4%37.89%38.02%36.26%32.88%33.93%34.88%36.5%33.14%33.09%34.42%34.93%34.98%33.68%30.57%29.29%32.8%31.46%33.03%
Selling, General & Admin3.26B3.13B3.1B3.09B3.05B2.88B2.9B2.92B2.95B2.7B2.69B2.72B2.75B2.84B2.73B2.76B2.79B3B2.77B2.72B
SG&A % of Revenue29.23%27.31%27.29%27.76%29.47%26.24%27.22%28.16%29.65%26.4%26.57%27.3%28.22%28.13%26.19%24.49%23.43%26.19%25.31%26.64%
Research & Development756M735M785M732M703M728M713M697M683M690M661M710M654M691M780M684M697M758M672M654M
R&D % of Revenue6.77%6.41%6.9%6.57%6.79%6.63%6.7%6.72%6.85%6.74%6.52%7.12%6.71%6.85%7.49%6.08%5.86%6.61%6.15%6.4%
Other Operating Expenses1000K1000K1000K1000K0000000000000000
Operating Income1.84B2.25B2.06B2.05B1.69B1.99B1.82B1.69B1.39B1.86B1.68B1.51B1.4B1.44B1.7B2.33B2.88B2.45B2.62B2B
Operating Margin %16.5%19.64%18.09%18.42%16.3%18.13%17.09%16.25%13.9%18.2%16.54%15.14%14.36%14.28%16.36%20.72%24.25%21.34%23.99%19.54%
Operating Income Growth %9.12%13.12%13.15%21.71%21.88%6.76%8.34%11.58%-1.07%29.35%-1.47%-35.23%-51.47%-41.11%-35.05%16.77%35.26%1.37%80.08%211.22%
EBITDA2.57B2.67B2.85B2.83B2.44B2.8B2.62B2.49B2.19B2.68B2.5B2.31B2.21B2.25B2.52B3.15B3.71B3.33B3.47B2.87B
EBITDA Margin %23.04%23.33%25.05%25.39%23.6%25.49%24.63%24.01%21.98%26.14%24.67%23.16%22.63%22.28%24.19%28.03%31.17%29.04%31.74%28.09%
EBITDA Growth %5.24%-4.43%8.74%13.57%11.6%4.48%4.68%7.79%-0.73%19.08%-0.64%-26.75%-40.51%-32.49%-27.41%9.85%20.9%1.52%53.22%95.77%
D&A (Non-Cash Add-back)730M422M791M777M756M807M801M805M805M813M824M800M806M807M815M822M823M883M847M874M
EBIT1.52B2.4B2.3B2.27B1.91B2.18B2.11B1.77B1.55B2.03B1.82B1.79B1.72B1.48B1.81B2.44B2.89B2.42B2.61B1.48B
Net Interest Income-68M-42M33M-50M-52M-61M-75M-86M-37M-146M-51M-55M-61M-76M-1M-59M4M-78M-109M-125M
Interest Income078M77M71M82M91M91M82M80M89M97M98M101M88M55M26M14M11M10M11M
Interest Expense68M120M44M121M134M152M166M168M117M235M148M153M162M164M56M85M10M89M119M136M
Other Income/Expense-393M107M123M98M90M40M122M-79M51M-69M-7M125M162M-121M55M19M-9M-120M-129M-650M
Pretax Income1.45B2.36B2.18B2.15B1.78B2.03B1.94B1.61B1.44B1.79B1.67B1.64B1.56B1.32B1.76B2.35B2.88B2.33B2.49B1.35B
Pretax Margin %12.98%20.58%19.17%19.3%17.17%18.5%18.24%15.49%14.41%17.53%16.47%16.4%16.03%13.08%16.89%20.89%24.18%20.29%22.81%13.19%
Income Tax372M582M536M371M453M-7.2B294M305M211M201M235M261M244M287M323M334M429M338M393M159M
Effective Tax Rate %25.67%24.68%24.59%17.26%25.48%-354.63%15.15%18.98%14.69%11.2%14.06%15.95%15.62%21.74%18.37%14.2%14.92%14.53%15.76%11.8%
Net Income1.08B1.78B1.64B1.78B1.32B9.23B1.65B1.3B1.23B1.59B1.44B1.38B1.32B1.03B1.44B2.02B2.45B1.99B2.1B1.19B
Net Margin %9.65%15.5%14.46%15.97%12.79%84.1%15.48%12.55%12.29%15.56%14.16%13.78%13.52%10.24%13.78%17.93%20.57%17.34%19.22%11.63%
Net Income Growth %-18.72%-80.76%-0.12%36.64%8.16%478.98%14.62%-5.31%-7.06%54.31%0.07%-31.86%-46.14%-48.06%-31.67%69.72%36.48%-8%70.45%121.42%
Net Income (Continuing)1.08B1.78B1.64B1.78B1.32B9.23B1.65B1.3B1.23B1.59B1.44B1.38B1.32B1.03B1.44B2.02B2.45B1.99B2.1B1.19B
Discontinued Operations00000000000000000000
Minority Interest640M641M310M264M253M237M232M242M233M224M213M230M222M219M209M226M230M222M216M229M
EPS (Diluted)0.621.020.941.010.765.270.940.740.700.910.820.780.750.590.811.141.381.121.170.66
EPS Growth %-18.24%-80.65%0%36.49%8.34%479.12%14.63%-5.13%-6.67%54.24%1.23%-31.58%-45.65%-47.32%-30.77%72.73%38%-7.44%69.57%120%
EPS (Basic)0.621.020.941.020.765.330.950.750.710.920.830.790.760.590.821.151.401.131.190.67
Diluted Shares Outstanding1.75B1.75B1.75B1.75B1.75B1.75B1.75B1.75B1.75B1.75B1.75B1.75B1.75B1.75B1.76B1.76B1.77B1.78B1.79B1.79B
Basic Shares Outstanding1.75B1.75B1.75B1.74B1.75B1.73B1.73B1.73B1.73B1.73B1.74B1.74B1.74B1.74B1.74B1.75B1.75B1.76B1.77B1.77B
Dividend Payout Ratio101.95%58%62.71%57.84%77.43%10.38%58.32%73.81%78.12%55.71%61.84%64.73%67.53%79.67%57.56%41.03%34%40.12%38.14%67.54%